Regarding prescription drug costs, politicians have officially approached the “be careful what you wish for” territory. Knee-jerk proposals from Congress and the Biden administration are piling on top of recently enacted government-required drug pricing policies. According to a recent study, lawmakers’ current direction will have seismic ramifications on developing lifesaving medicines and cost Americans access to these medications and sought-after jobs. Federal regulatory agencies are implementing government drug pricing provisions from the Inflation […]
Author Archives: Tom Kowalski
Tom Kowalski is chair of We Work For Health, an organization that works with biopharmaceutical research companies and manufacturers. He wrote this for InsideSources.com.